Amgen Inc. $AMGN is China Universal Asset Management Co. Ltd.'s 9th Largest Position

robot
Abstract generation in progress

China Universal Asset Management Co. Ltd. significantly increased its stake in Amgen Inc. by 10.7% during the fourth quarter, making it the firm’s ninth-largest holding, valued at $23.41 million. Despite mixed analyst ratings, with an average “Hold” and a target price of $356.62, Amgen recently completed an early-stage cancer study and reported a strong Q4 earnings beat, along with setting its FY 2026 EPS guidance. However, upcoming Q1 earnings are expected to decline, and insider selling has been observed.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin